Dar Al Dawa Development and Investment (AMM:DADI) ROCE % : 11.22% (As of Mar. 2024)

View and export this data going back to 1978. Start your Free Trial

What is Dar Al Dawa Development and Investment ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Dar Al Dawa Development and Investment's annualized ROCE % for the quarter that ended in Mar. 2024 was 11.22%.

Dar Al Dawa Development and Investment ROCE % Historical Data

The historical data trend for Dar Al Dawa Development and Investment's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Dar Al Dawa Development and Investment ROCE % Chart

Dar Al Dawa Development and Investment Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

ROCE %

Get a 7-Day Free Trial

-9.27

30.85

7.97

9.75

13.71

Dar Al Dawa Development and Investment Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
ROCE %	Get a 7-Day Free Trial															9.58	14.23	21.40	8.59	11.22

Dar Al Dawa Development and Investment ROCE % Calculation

Dar Al Dawa Development and Investment's annualized ROCE % for the fiscal year that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	6.409	/	( ( (107.172 - 60.567)	+	(109.248 - 62.336) )	/ 2 )
	=	6.409	/	( (46.605	+	46.912)	/ 2 )
	=	6.409	/	46.7585
	=	13.71 %

Dar Al Dawa Development and Investment's ROCE % of for the quarter that ended in Mar. 2024 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Mar. 2024 )		(Q: Dec. 2023 )		(Q: Mar. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Mar. 2024 )		(Q: Dec. 2023 )		(Q: Mar. 2024 )
	=	5.66	/	( ( (109.248 - 62.336)	+	(113.235 - 59.258) )	/ 2 )
	=	5.66	/	( ( 46.912	+	53.977 )	/ 2 )
	=	5.66	/	50.4445
	=	11.22 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2024) EBIT data.

Dar Al Dawa Development and Investment (AMM:DADI) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Dar Al Dawa Development and Investment ROCE % Related Terms

Thank you for viewing the detailed overview of Dar Al Dawa Development and Investment's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Dar Al Dawa Development and Investment (AMM:DADI) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Dar Al Dawa Development and Investment (AMM:DADI) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

N/A

Address

Naour, P.O. Box 9364, Amman, JOR, 11191

Website

https://www.dadgroup.com

Dar Al Dawa Development and Investment is a pharmaceutical company. The main objectives of the company are to manufacture pharmaceutical, chemical, pharmaceutical, and related products and to import medicines. It offers products in the therapeutic areas of anti-infective, cardiovascular and diabetes, dermatology, eye-ear preparations, gastroenterology and metabolism, genitourinary system and sex hormones, musculoskeletal system, nervous system, ophthalmological/otological, and respiratory system, as well as vitamins. The company's geographical segments are Levant and Iraq, Gulf and Yemen, Africa, and Europe and Asia.

Dar Al Dawa Development and Investment (AMM:DADI) Headlines

No Headlines